Effect of Addition of Steroids on Duration of Analgesia
Key facts
- Who runs it
- University of California, Los Angeles
- Where
- Chapel Hill and Westwood, Los Angeles, United StatesSee the 2 sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Early phase 1
- People taking part
- 28 people enrolled
- Started
- 6 Jan 2022
- Expected to end
- 2 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Triamcinolone
- Bupivacaine
- Iohexol contrast
- Record updated
- 12 November 2026
Who can take part
- Age
- 30 years to 60 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- females
- aged between 30 and 60 years
- diagnosed with symptomatic uterine fibroids and/or adenomyosis and scheduled to undergo UAE procedure
Who cannot take part
- Allergies to local anesthetic or steroid agent
- History of inflammatory bowel disease or ulcerative colitis
- Diabetes mellitus
- Contraindications to UAE
- SHNB is deemed unsafe for the patient
- Uncorrectable abnormal coagulation profile
Where in United States
- University of North CarolinaChapel Hill, United States
- University of California, Los AngelesWestwood, Los Angeles, United States
About the trial
What the trial wants to find out
The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.
The 2 groups in the trial
- BupivacaineExisting treatment, for comparison
During the Uterine Artery Embolization (UAE) procedure, participants in this arm receive bupivacaine and contrast to enable visualization of the nerve block under fluoroscopy.
Treatment: Bupivacaine and Iohexol contrast
- Bupivacaine and TriamcinoloneTreatment being tested
During the Uterine Artery Embolization (UAE) procedure, participants in this arm receive bupivacaine plus triamcinolone mixed with contrast to enable visualization of the nerve block under fluoroscopy.
Treatment: Triamcinolone, Bupivacaine, and Iohexol contrast
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Randomized Controlled Clinical Trial: Superior Hypogastric Nerve Block for Pain Control After Uterine Artery Embolization: Effect of Addition of Steroids on Duration of Analgesia
- Record updated
- 12 November 2026